Sentinel node localization in primary melanoma: Preoperative dynamic lymphoscintigraphy, intraoperative gamma probe, and vital dye guidance

Surgery

Volumn 127, Issue 1, 2000, Pages 19-25

  Gennari, Roberto ^a,b,c   Bartolomei, M ^a,b,c   Testori, A ^a,b,c   Zurrida, S ^a,b,c   Stoldt, H S ^a,b,c   Audisio, R A ^a,b,c   Geraghty, J G ^a,b,c   Paganelli, G ^a,b,c   Veronesi, U ^a,b,c  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISULFINE BLUE; TECHNETIUM 99M;

ADULT; ARTICLE; BODY DISTRIBUTION; FEMALE; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MELANOMA; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL TECHNIQUE; VITAL STAIN;

EID: 0033958210     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2000.100722     Document Type: Article

References (35)

1. 1. Koh HK. Cutaneous melanoma. N Engl J Med 1991;325:171-82.
2. 2. Parker SL, Tong T, Bolden S, et al. Cancer statistics. Cancer J Clin 1996;46:5-28.
3. 3. Balch CM, Soong S-J, Milton GW, et al. A comparison of prognostic factors and surgical results in 1786 patients with localized (stage I) melanoma treated in Alabama, USA and New South Wales, Australia. Ann Surg 1982;196:677-84.
4. 4. Miller DR, Geller AC, Wyatt SW, et al. Melanoma awareness and self-examination practices: results of a United States survey. J Am Acad Dermatol 1996:34:962-70.
5. 5. Veronesi U, Cascinelli N. Narrow excision (1 cm-margin): a safe procedure for thin cutaneous melanoma. Arch Surg 1991:126:438-41.
6. 6. Veronesi U, Cascinelli N, Adamus J, et al. Thin stage 1 primary cutaneous malignant melanoma: comparison of excision with margin of 1 or 3 cm. N Engl J Med 1988;318:1159-1162.
7. 7. Balch CM, Urist MM, Karakousis CP. et al. Efficacy of 2 cm surgical margins for intermediate thickness melanomas (1 to 4 mm): result of multi-institutional randomized surgical trial. Ann Surg 1993;218:262-7.
8. 8. Veronesi U, Adamus J, Baudiera DC, et al. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med 1977:297:627-30.
9. 9. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992:127:392-9.
10. 10. Morton DL, Wen DR, Cochran AJ. Management of early stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy: an alternative to routine lymphadenectomy or "watch and wait." Surg Oncol Clin N Am 1992:1:247-59.
11. 11. Wong JH, Cagle LA, Morton DL. Lymphatic drainage of skin to sentinel node in a feline model. Ann Surg 1991;214:637-41.
12. 12. Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994:220:759-67.
13. 13. Albertini JJ, Cruse WC, Rapaport D, et al. Intraoperative radiolymphoscintigraphy improves sentinel node identification for patients with melanoma. Ann Surg 1996:223:217-24.
14. 14. Cascinelli N, Morabito A, Santinami M, et al. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomized trial. WHO Melanoma Programme. Lancet 1998;351:793-6.
15. 15. Reintgen D, Balch MB, Kirkwood J, et al. Recent advances in the care of the patient with malignant melanoma. Ann Surg 1997;225:1-14.
16. 16. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997;349:1864-7.
17. 17. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;3:456-66.
18. 18. Cabanas RM. Anatomy and biopsy of sentinel nodes. Urol Clin North Am 1992;19:267-76.
19. 19. Kapteijn BAE, Nieweg OE, Liem I, et al. Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye. Ann Surg Oncol 1997:4:156-60.
20. 20. Pijpers R, Borgstein PJ, Meijer S, et al. Sentinel node biopsy in melanoma patients: dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital dye guidance. World J Surg 1997;21:788-93.
21. 21. Ramnath EM, Kamath D, Brobeil A, et al. Lymphatic mapping for melanoma: long-term results of regional nodal sampling with radioguided surgery. Cancer Control: JMMC 1997;4:483-90.
22. 22. Leong SPL, Stenmetz I, Habib FA, et al. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg 1997;132:666-73.
23. 23. Krag DN, Sybern JM, Weaver DL, et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995:130:654-58.
24. 24. Thompson JF, McCarthy WH, Bosch CMJ, et al. Sentinel lymph node status as indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995:5:255-60.
25. 25. Lingam MK, Mackie RM, Mackay AJ. Intraoperative lymphatic mapping using patent blue V dye to identify nodal micrometastases in malignant melanoma. Reg Cancer Treat 1994;7:144-6.
26. 26. Godellas CV, Berman CG, Lyman G, et al. The identification and mapping of melanoma regional nodal metastases: minimally invasive surgery for the diagnosis of nodal metastases. Am Surg 1995;61:97-101.
27. 27. Reintgen DS, Albertini J, Berman C, et al. Accurate nodal staging of malignant melanoma. Cancer control: Journal of the Moffit Cancer Center 1995;2:405-14.
28. 28. Brossart P, Schmier J, Kruger S, et al. A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood. Cancer Res 1995;55:4065-8.
29. 29. Balch CM, Wilkerson JA, Murad TM, et al. The prognostic significance of ulceration of cutaneous melanoma. Cancer 1980;45:3012-7.
30. 30. Reintgen DS, Paull DE, Seigier HF, et al. Sex-related survival differences in instance of melanoma. Surg Gynecol Obstet 1984;159:362-7.
31. 31. Ustin P, Cruse CW, Lyman G, et al. The role of age as prognostic factor in the malignant melanoma population. Ann SurgOncol 1994;1:487-94.
32. 32. Singluff C, Vollmer R, Reintgen DS, et al. Lethal malignant melanoma. Ann Surg 1988;208:150-61.
33. 33. D'Emilia JC, Lawrence W Jr. Sentinel lymph node biopsy in malignant melanoma: the standard of care? J Surg Oncol 1997;65:153-4.
34. 34. Ross MI. Surgical management of stage I and II melanoma patients: approach to the regional lymph node basin. Semin Surg Oncol 1996;12:394-401.
35. 35. Kirkwood JM, Strawderman MH, Ernsoff MS, et al. Interferon alfa-2b adjuvant therapy of high risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group trial EST 1684. J Clin Oncol 1996;14:7-17.